Vanguard Global Infrastructure ETF (VBLD) Stock Price, News, Quotes-Moomoo

AU ETFDetailed Quotes

VBLD Vanguard Global Infrastructure ETF

Watchlist

69.490
-0.170-0.24%

20min DelayNot Open Sep 13 15:59 AET

69.680High69.230Low

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Least Shorted S&P 500 Stocks in August
Seeking AlphaSep 15 09:36 ET
Insider Trades: Notable Buys and Sells by Significant Shareholders, Executives and Directors
Seeking AlphaSep 14 13:21 ET
Catalyst Watch: FOMC, FedEx Earnings, Electronic Arts Event, and Triple Witching Day
Seeking AlphaSep 13 15:00 ET
Short Sellers Raise Bets Against Industrial Sector in August
Seeking AlphaSep 13 11:13 ET
Chevron Tops List of Most Shorted Large-cap Stocks in August, Hazeltree Says
Seeking AlphaSep 13 06:04 ET
Duke Energy Corporation 5.625% JR SB DB Goes Ex-dividend Tomorrow
Seeking AlphaSep 12 12:50 ET

Comments

Moomoo AI

Oct 17, 2023 02:08

The trial of VB-601 may add value but hiring an advisor for strategic options and reporting losses indicate resource pressure and strategy shift, thus casting doubt on future performance.

Press Release: VBL Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Moomoo AI

Oct 17, 2023 02:04

Matthew Trudeau's appointment as CCO massively benefits VBL, given his extensive experience in leading commercial practices at different biotech firms. His expertise is expected to be crucial in preparing for the anticipated OVAL Phase 3 trial readout in the second half of 2022.

Press Release: VBL Therapeutics Announces Appointment of Matthew Trudeau as Chief Commercial Officer

Moomoo AI

Oct 17, 2023 02:04

EIC Accelerator funds VBL as it approaches the final enrollment phase of its key product candidate, ofra-vec (VB-111), for ovarian cancer. The CEO perceives this investment as acknowledgment of the potential ofra-vec offers to patients and the current critical need in ovarian cancer therapies.

Press Release: VBL Therapeutics Selected for EUR17.5 Million of Funding from Horizon Europe EIC Accelerator Program